Literature DB >> 19167251

Brain injury in glutaric aciduria type I: the value of functional techniques in magnetic resonance imaging.

Belén Pérez-Dueñas1, Alberto De La Osa, Antoni Capdevila, Aleix Navarro-Sastre, Andy Leist, Antonia Ribes, Angels García-Cazorla, Mercedes Serrano, Mercedes Pineda, Jaume Campistol.   

Abstract

BACKGROUND: Acute striatal necrosis is a devastating consequence of encephalopathic crisis in patients with glutaric aciduria type I (GA-I), but the mechanisms underlying brain injury are not completely understood.
OBJECTIVE: To approach pathophysiological aspects of brain injury in GA-I by means of functional techniques in magnetic resonance imaging (MRI). PATIENTS AND METHODS: Four patients during an acute encephalopathic crisis and three asymptomatic siblings with GA-I underwent single-voxel hydrogen magnetic resonance spectroscopy (MRS) and brain MRI including gradient echo T1-weighted, FLAIR, T2-weighted and diffusion-weighted imaging.
RESULTS: The study was performed between three and eight days after the onset of acute encephalopathic crisis. Isotropic diffusion images showed high signal changes with corresponding low apparent diffusion coefficient values within the putamen, caudate nuclei and globus pallidus (four patients), and the cerebral peduncles including the substantia nigra (one patient). The study disclosed normal findings in asymptomatic siblings. MRS showed decreased N-acetyl-aspartate/creatine ratio at the basal ganglia in encephalopathic patients when compared to a group of sex- and age-matched controls.
CONCLUSIONS: Brain injury in GA-I is characterized by the presence of cytotoxic edema and reduced neuronal integrity by functional imaging techniques. Involvement of the basal ganglia may be asymmetrical in patients with unilateral motor disorder and may extent to the cerebral peduncles and substantia nigra, which may be responsible for the acute onset dystonia in some patients. Functional techniques failed to demonstrate any abnormalities in asymptomatic patients, which is in agreement with the integrity of basal ganglia structures observed by conventional MRI sequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167251     DOI: 10.1016/j.ejpn.2008.12.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

1.  Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystonia.

Authors:  Jose Felix Marti-Masso; Javier Ruiz-Martínez; Vladimir Makarov; Adolfo López de Munain; Ana Gorostidi; Alberto Bergareche; Seungtai Yoon; Joseph D Buxbaum; Coro Paisán-Ruiz
Journal:  Hum Genet       Date:  2011-09-13       Impact factor: 4.132

2.  (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.

Authors:  Inga Harting; Nikolas Boy; Jana Heringer; Angelika Seitz; Martin Bendszus; Petra J W Pouwels; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

3.  Thiamine transporter-2 deficiency: outcome and treatment monitoring.

Authors:  Juan Darío Ortigoza-Escobar; Mercedes Serrano; Marta Molero; Alfonso Oyarzabal; Mónica Rebollo; Jordi Muchart; Rafael Artuch; Pilar Rodríguez-Pombo; Belén Pérez-Dueñas
Journal:  Orphanet J Rare Dis       Date:  2014-06-23       Impact factor: 4.123

4.  Audiological and otologic manifestations of glutaric aciduria type I.

Authors:  Yen-Chi Chen; Chii-Yuan Huang; Yen-Ting Lee; Chia-Hung Wu; Sheng-Kai Chang; Hsiu-Lien Cheng; Po-Hsiung Chang; Dau-Ming Niu; Yen-Fu Cheng
Journal:  Orphanet J Rare Dis       Date:  2020-12-01       Impact factor: 4.123

5.  Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I.

Authors:  Valeska Lizzi Lagranha; Ursula Matte; Talita Giacomet de Carvalho; Bianca Seminotti; Carolina Coffi Pereira; David M Koeller; Michael Woontner; Stephen I Goodman; Diogo Onofre Gomes de Souza; Moacir Wajner
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

6.  Functional Recovery of a GCDH Variant Associated to Severe Deflavinylation-Molecular Insights into Potential Beneficial Effects of Riboflavin Supplementation in Glutaric Aciduria-Type I Patients.

Authors:  Joana V Ribeiro; Cláudio M Gomes; Bárbara J Henriques
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.